文章摘要
闫丽娟2 康燕2 李宝华2.循环DNA 和HBV-DNA 载量与原发性肝癌的相关性探讨[J].,2011,11(19):3713-3715
循环DNA 和HBV-DNA 载量与原发性肝癌的相关性探讨
Correlation of Circulating DNA and HBV-DNA Load and PrimaryLiver Cancer
  
DOI:
中文关键词: 原发性肝癌  血循环DNA  HBV-DNA
英文关键词: PHC  Blood circulating DNA  HBV-DNA
基金项目:
作者单位
闫丽娟2 康燕2 李宝华2 青岛大学医学院微生物学教研室 
摘要点击次数: 507
全文下载次数: 888
中文摘要:
      目的:探讨血浆DNA 和HBV-DNA 载量在病毒性肝炎肝硬化后原发性肝癌(PHC)的诊断价值。方法:用RT-PCR 方法随访 检测HBsAg 阳性且经彩色B 超诊断为肝硬化的患者,每6 个月检测一次患者的血液循环DNA 和HBV-DNA 载量,直到经临床 症状、彩色B 超、CT 诊断为原发性肝癌为止。结果:在PHC 中,循环DNA 61.3±31.9ng/ml,健康对照组20.3±9.9ng/ml,两组差异 显著(P<0.01);而HBV-DNA 载量,在PHC 确诊时多数处于较低水平,78%≤105copies/ml,与PHC 确诊前有明显差异(P< 0.01)。PHC 未发生淋巴结转移者循环DNA 51.2±17.9ng/ml,淋巴结转移者循环DNA 73.9±23.7ng/ml,两者存在差异(P<0.05); 而HBV-DNA 载量有无淋巴结转移无明显差异。结论:联合检测血液循环DNA 和HBV-DNA 载量对PHC 的预测、预后价值明 显,且方法简单,易于开展。
英文摘要:
      Objective: To explore the diagnosis value of plasma DNA and HBV-DNA load for PHC after viral hepatitis cirrhosis. Methods: Follow-up with RT -PCR to test the hepatitis cirrhosis patients by Color B ultrasonic diagnosis who HBsAg is positive. To test the patients with blood circulating DNA and HBV-DNA load every six months,until diagnosis of PHC by the clinical symptoms, color B ultrasonic and CT. Results: Blood circulating DNA is 61.3±31.9ng/ml in PHC, health control group is 20.3±9.9ng/ml, two groups have significant difference (P<0.01), and HBV-DNA load is low level,78%≤105copies/ml,and have obvious difference with PHC who has not diagnosed (P<0.01). The blood circulating DNA of PHC who has not occurred lymph node metastasis is 51.2±17.9ng/ml, who has occurred lymph node metastasis is 73.9±23.7ng/ml, differences exist between them (P<0.05); But HBV-DNA load has no obvious difference between patients with or without lymph node metastasis. Conclusion: United detecting of the blood circulating DNA and HBV-DNA load for the forecasting and prognosis value of the PHC is obvious, and the method is simple, and easy to carry out.
查看全文   查看/发表评论  下载PDF阅读器
关闭